LI LIAO to Humans
This is a "connection" page, showing publications LI LIAO has written about Humans.
Connection Strength
0.046
-
Nuclear export of R-loop by the DDX1 and XPO1 complex promotes senescence-associated secretory phenotype and inflammaging. Nat Aging. 2026 Jun; 6(6):1208-1226.
Score: 0.007
-
Selective Alanine Transporter Utilization Is a Therapeutic Vulnerability in ARID1A-Mutant Ovarian Cancer. Cancer Res. 2025 09 15; 85(18):3471-3489.
Score: 0.006
-
Targeting branched N-glycans and fucosylation sensitizes ovarian tumors to immune checkpoint blockade. Nat Commun. 2024 Apr 02; 15(1):2853.
Score: 0.006
-
Survival outcomes and toxicity of adjuvant immunotherapy after definitive concurrent chemotherapy with proton beam radiation therapy for patients with inoperable locally advanced non-small cell lung carcinoma. Radiother Oncol. 2024 04; 193:110121.
Score: 0.006
-
Multiple-CT optimization: An adaptive optimization method to account for anatomical changes in intensity-modulated proton therapy for head and neck cancers. Radiother Oncol. 2020 01; 142:124-132.
Score: 0.004
-
Multiple-CT optimization of intensity-modulated proton therapy - Is it possible to eliminate adaptive planning? Radiother Oncol. 2018 07; 128(1):167-173.
Score: 0.004
-
Motion-robust intensity-modulated proton therapy for distal esophageal cancer. Med Phys. 2016 Mar; 43(3):1111-8.
Score: 0.003
-
Selective robust optimization: A new intensity-modulated proton therapy optimization strategy. Med Phys. 2015 Aug; 42(8):4840-7.
Score: 0.003
-
Proton energy optimization and reduction for intensity-modulated proton therapy. Phys Med Biol. 2014 Nov 07; 59(21):6341-54.
Score: 0.003
-
Evaluation and mitigation of the interplay effects of intensity modulated proton therapy for lung cancer in a clinical setting. Pract Radiat Oncol. 2014 Nov-Dec; 4(6):e259-68.
Score: 0.003
-
On the interplay effects with proton scanning beams in stage III lung cancer. Med Phys. 2014 Feb; 41(2):021721.
Score: 0.003